Sign Out
Pregnancy: Pregnancy category C.
Administration of Brompheniramine and Phenylephrine in late pregnancy, show possible harms to the fetus, and there are the risks of severe reactions (e.g. seizure) of antihistamine use in neonates. There is no adequate safety and efficacy information in pregnancy. Hence, use this product during pregnancy only if the potential benefit justifies the risk to the mother and fetus.
Lactation: It is not known whether Brompheniramine and Glyceryl guaiacolate (for expectorant only) are distributed into milk. However, Phenylephrine does not appear to be distributed into breast milk. There is no adequate safety and efficacy information in lactation. Therefore, physician should carefully consider discontinuing nursing during drug use or discontinuing the drug. Taking into account the importance of the drugs to the nursing women and possible risks to infants nursing.
